Condition: Lung Cancer, Non-Small Cell · Lung Infection · Sponsor: Peking University Cancer Hospital & Institute
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
This description comes directly from the study's public registry record.
Nan Li · +86-13693090647 · rainbow6283@sina.com
Xin Zhou, MD · zhouxinbjmu@163.com
Always discuss trial participation with your own doctor first.
| Peking University Cancer Hospital & Institute | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06648317